Drug Profile
Monoclonal antibody 4E3-CPA conjugate
Latest Information Update: 12 Feb 2007
Price :
$50
*
At a glance
- Originator BCM Oncologia
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ovarian cancer
Most Recent Events
- 11 May 1999 Preclinical development for Ovarian cancer in Canada (unspecified route)